Anti-AgingResearch17 providers

NAD+ Therapy: Complete Guide

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells that plays a critical role in energy metabolism, DNA repair, and cell signaling. NAD+ levels naturally decline with age, and this decline is associated with numerous age-related diseases. NAD+ therapy, delivered via IV infusion or subcutaneous injection, aims to restore youthful NAD+ levels.

Typical cost: $200 - $800/month

Written by

Megan Williams

Editor-in-Chief

Reviewed by

Brian Williams

Co-founder & Research Editor

Last updated

May 26, 2026

What is NAD+?

What Is NAD+?

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every living cell and is essential for life. It plays a critical role in hundreds of metabolic reactions, including cellular energy production, DNA repair, gene expression regulation, and cellular signaling. NAD+ exists in two forms: NAD+ (oxidized) and NADH (reduced), and the ratio between them is critical for cellular metabolism.

NAD+ levels decline significantly with age — studies suggest a 50% reduction between ages 40 and 60. This decline is associated with many hallmarks of aging, including mitochondrial dysfunction, DNA damage accumulation, and impaired cellular repair mechanisms. The restoration of NAD+ levels has emerged as one of the most promising strategies in longevity and regenerative medicine.

Administration Methods

NAD+ is available through several routes:

Intravenous (IV) infusion: The most direct method, achieving the highest blood levels. Typically administered in clinical settings over 2–4 hours.
Subcutaneous injection: Increasingly popular for maintenance dosing; convenient and effective.
Intramuscular injection: Less common but used by some practitioners.
Oral precursors: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are oral supplements that boost NAD+ levels indirectly.
Nasal spray: Emerging route of administration for direct CNS access.

Clinical Applications

Anti-aging and longevity: Restoring cellular energy and repair capacity
Neurodegenerative disease: Supporting neuronal health and cognitive function
Addiction recovery: NAD+ IV therapy has been used in addiction treatment protocols
Chronic fatigue: Improving mitochondrial function and cellular energy production
Athletic performance: Enhancing cellular energy metabolism and recovery

How NAD+ Works

Cellular Energy Production

NAD+ is a critical coenzyme in mitochondrial energy production, serving as an electron carrier in the electron transport chain. It participates in:

Glycolysis: NAD+ accepts electrons during glucose breakdown
TCA cycle (Krebs cycle): NAD+ is essential for multiple steps of the cycle
Oxidative phosphorylation: NADH donates electrons to Complex I of the electron transport chain, driving ATP synthesis

Sirtuin Activation

NAD+ is the essential substrate for sirtuins (SIRT1-7), a family of enzymes often called "longevity genes." Sirtuins regulate:

DNA repair: SIRT1 and SIRT6 are critical for maintaining genomic stability
Mitochondrial biogenesis: SIRT1 activates PGC-1α, promoting new mitochondria formation
Inflammation control: Sirtuins regulate NF-κB and other inflammatory pathways
Epigenetic regulation: Histone deacetylation by sirtuins influences gene expression patterns
Circadian rhythm: SIRT1 regulates the molecular clock

PARP-Mediated DNA Repair

NAD+ is consumed by PARP enzymes (Poly-ADP-Ribose Polymerases), which are essential for DNA damage detection and repair. As DNA damage accumulates with age, PARP activity increases, further depleting NAD+ levels and creating a vicious cycle of declining repair capacity.

CD38 and NAD+ Consumption

The enzyme CD38, which increases with age and inflammation, is a major NAD+ consumer. CD38 activity is believed to be one of the primary drivers of age-related NAD+ decline, making NAD+ supplementation a strategy to overcome this enzymatic consumption.

Benefits & Uses

Evidence-Based Benefits of NAD+ Therapy

Cellular energy restoration: By replenishing a critical coenzyme, NAD+ therapy can restore mitochondrial function and cellular energy production. Patients frequently report improved energy levels and reduced fatigue.
DNA repair enhancement: NAD+ fuels both sirtuin-mediated and PARP-mediated DNA repair pathways. Animal studies show that NAD+ repletion restores DNA repair capacity in aged tissues (Fang et al., Cell Metabolism, 2016).
Cognitive function support: Preclinical studies demonstrate that NAD+ repletion through NMN supplementation improves cognitive function and reduces neuroinflammation in aging mouse models (Hou et al., Cell Metabolism, 2018).
Mitochondrial function: NAD+ activates SIRT1/PGC-1α pathway, promoting mitochondrial biogenesis and improving mitochondrial quality control through mitophagy.
Inflammatory regulation: Sirtuin activation through NAD+ helps regulate inflammatory responses, potentially beneficial for chronic inflammatory conditions.
Addiction recovery support: NAD+ IV therapy has been used in addiction treatment centers with reported improvements in withdrawal symptoms and cravings, though controlled clinical trials are limited (Mestayer, Brain Research Foundation reports).
Cardiovascular support: Animal studies show NAD+ repletion improves vascular function, reduces arterial stiffness, and protects against age-related cardiovascular decline (de Picciotto et al., Aging Cell, 2016).
Metabolic improvement: Studies show NAD+ precursors improve insulin sensitivity and metabolic parameters in animal models and early human trials.

Clinical Evidence & Research

Research Evidence

NAD+ decline with age (Camacho-Pereira et al., Cell Metabolism, 2016): Established that CD38 is a primary driver of age-related NAD+ decline, and that CD38 inhibition restores NAD+ levels and improves metabolic function in aging mice.

DNA repair (Fang et al., Cell Metabolism, 2016): Demonstrated that NAD+ repletion with NMN restored DNA repair capacity in aged mice and improved cellular function, establishing a mechanistic link between NAD+ decline and age-related genomic instability.

Neurocognitive function (Hou et al., Cell Metabolism, 2018): NMN supplementation improved cognitive function, reduced neuroinflammation, and restored synaptic plasticity in aged mouse models, suggesting potential for neurodegenerative disease prevention.

Human NMN trial (Yoshino et al., Science, 2021): Randomized, double-blind, placebo-controlled trial of oral NMN (250 mg/day) in overweight/obese postmenopausal women showed improved muscle insulin sensitivity and insulin signaling after 10 weeks.

Exercise performance (Liao et al., Journal of the International Society of Sports Nutrition, 2021): NMN supplementation improved aerobic capacity in recreational runners during exercise training, with increased oxygen utilization and ventilatory threshold.

Vascular health (de Picciotto et al., Aging Cell, 2016): NMN supplementation reversed age-related vascular dysfunction in mice, improving endothelial function and reducing arterial stiffness.

"NAD+ decline is a fundamental feature of aging that contributes to multiple age-related diseases. Restoring NAD+ levels represents a promising therapeutic strategy." — Imai & Guarente, Trends in Cell Biology, 2014

Side Effects & Safety

Side Effect Profile

NAD+ therapy is generally well-tolerated, though side effects vary by administration route.

IV NAD+ Infusion Side Effects

Chest tightness or pressure — Common during IV infusion if the rate is too fast. Managed by slowing the infusion rate.
Nausea and abdominal cramping — Occurs if the infusion rate is too rapid. Resolves with rate reduction.
Headache — Reported during or shortly after infusion; usually self-limiting.
Lightheadedness — Transient; may relate to vasodilation effects.
Muscle cramping — Occasionally reported during IV infusion.

Subcutaneous/Intramuscular Injection Side Effects

Injection site pain — NAD+ injections can cause a stinging or burning sensation at the injection site. This is the most commonly reported side effect.
Injection site redness — Mild erythema and swelling; typically resolves within hours.
Nausea — Less common than with IV but can occur, particularly at higher doses.

General Considerations

Sleep disruption: If administered late in the day, NAD+ may cause increased energy and difficulty sleeping. Morning or early afternoon dosing is preferred for injections.
Flushing: Transient warmth or redness, particularly with higher doses.

Most side effects of IV NAD+ are infusion-rate dependent and can be managed by adjusting the infusion speed. Subcutaneous injection avoids most IV-related side effects but may cause local discomfort.

Dosing & Administration

Common Dosing Protocols

IV NAD+ Infusion

Standard dose: 250–750 mg per infusion (some protocols use up to 1,000 mg)
Infusion time: 2–4 hours, adjusted based on tolerance
Frequency: Loading protocol of 2–4 infusions over 1–2 weeks, followed by monthly maintenance infusions

Subcutaneous Injection

Standard dose: 50–200 mg subcutaneously, 2–5 times weekly
Maintenance: 50–100 mg 2–3 times weekly after initial loading phase

Oral Precursors (NMN/NR)

NMN: 250–1,000 mg orally daily
NR: 250–500 mg orally daily

Timing: Morning dosing is preferred due to NAD+'s energizing effects and its role in circadian rhythm regulation.

Clinical note: Many practitioners start with a series of IV NAD+ infusions for rapid repletion, then transition to subcutaneous injections or oral precursors for maintenance. The combination of injectable NAD+ with oral NMN is a popular maintenance strategy.

Find NAD+ Providers Near You

Browse 17 verified providers offering NAD+ therapy in our directory. Compare clinics by location, telehealth availability, insurance acceptance, and patient reviews.

Browse Providers

NAD+ FAQ

IV NAD+ provides the highest blood levels most quickly, as it bypasses absorption entirely. Subcutaneous injections provide good bioavailability with convenience. Oral precursors (NMN, NR) are converted to NAD+ in the body but have variable bioavailability. Many practitioners use IV for initial loading, then transition to injections or oral supplements for maintenance.

NAD+ must be infused slowly (over 2-4 hours) because rapid infusion can cause uncomfortable side effects including chest tightness, nausea, and abdominal cramping. The slow rate allows the body to process and utilize the NAD+ without triggering these adverse reactions. Faster rates may be tolerated with experience.

Both NMN and NR raise NAD+ levels, but through slightly different pathways. NMN is one step closer to NAD+ in the biosynthetic pathway and has more recent clinical trial data supporting its efficacy. NR has a longer track record with published human studies. Both are considered effective, and some practitioners recommend combining them.

While direct NAD+ level testing is available through specialized labs, it is not yet standardized. Common symptoms of NAD+ decline include chronic fatigue, brain fog, poor recovery from exercise, accelerated aging signs, and increased susceptibility to illness. Age alone is a strong predictor, as NAD+ levels decline approximately 50% between ages 40 and 60.

NAD+ is essential for mitochondrial energy production, and many patients with chronic fatigue report significant improvement with NAD+ therapy. By restoring cellular energy production capacity and supporting mitochondrial function, NAD+ can address one of the fundamental mechanisms of fatigue. However, chronic fatigue often has multiple contributing factors that should be addressed comprehensively.

NAD+ is a naturally occurring coenzyme essential for life, and replenishing declining levels is generally considered safe. Long-term studies with oral precursors (NMN, NR) have not revealed significant safety concerns. However, very long-term data (decades) is not yet available. Regular monitoring and working with a knowledgeable provider is recommended for ongoing therapy.